39 related articles for article (PubMed ID: 8093369)
1. LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells.
Zhang J; Sommermann T; Li X; Gieselmann L; de la Rosa K; Stecklum M; Klein F; Kocks C; Rajewsky K
Front Immunol; 2023; 14():1331730. PubMed ID: 38169736
[TBL] [Abstract][Full Text] [Related]
2. A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent.
Maier S; Santak M; Mantik A; Grabusic K; Kremmer E; Hammerschmidt W; Kempkes B
J Virol; 2005 Jul; 79(14):8784-92. PubMed ID: 15994772
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression.
Guo R; Zhang Y; Teng M; Jiang C; Schineller M; Zhao B; Doench JG; O'Reilly RJ; Cesarman E; Giulino-Roth L; Gewurz BE
Nat Microbiol; 2020 Aug; 5(8):1051-1063. PubMed ID: 32424339
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent genes.
Kang MS; Kieff E
Exp Mol Med; 2015 Jan; 47(1):e131. PubMed ID: 25613728
[TBL] [Abstract][Full Text] [Related]
5. Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells.
Nanbo A; Kawanishi E; Yoshida R; Yoshiyama H
J Virol; 2013 Sep; 87(18):10334-47. PubMed ID: 23864627
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism analysis of Epstein-Barr virus isolates of nasopharyngeal carcinoma biopsies from Tunisian patients.
Ayadi W; Feki L; Khabir A; Boudawara T; Ghorbel A; Charfeddine I; Daoud J; Frikha M; Hammami A; Karray-Hakim H
Virus Genes; 2007 Apr; 34(2):137-45. PubMed ID: 17216568
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the Epstein-Barr virus latent membrane protein-1 (BNLF-1) gene in spontaneous lymphoblastoid cell lines: effect on in vitro transformation associated parameters and tumorigenicity in SCID and nude mice.
Sandvej K; Munch M; Hamilton-Dutoit S
Clin Mol Pathol; 1996 Oct; 49(5):M290-7. PubMed ID: 16696091
[TBL] [Abstract][Full Text] [Related]
8. Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: implications for its role in the development of EBV genome-positive T-cell lymphomas.
Xu J; Ahmad A; Menezes J
J Virol; 2002 Apr; 76(8):4080-6. PubMed ID: 11907247
[TBL] [Abstract][Full Text] [Related]
9. 14-3-3 proteins are required for the inhibition of Ras by exoenzyme S.
Henriksson ML; Trollér U; Hallberg B
Biochem J; 2000 Aug; 349 Pt 3(Pt 3):697-701. PubMed ID: 10903129
[TBL] [Abstract][Full Text] [Related]
10. The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes.
Johnson RJ; Stack M; Hazlewood SA; Jones M; Blackmore CG; Hu LF; Rowe M
J Virol; 1998 May; 72(5):4038-48. PubMed ID: 9557692
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
Lay JD; Tsao CJ; Chen JY; Kadin ME; Su IJ
J Clin Invest; 1997 Oct; 100(8):1969-79. PubMed ID: 9329960
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus.
Mitchell T; Sugden B
J Virol; 1995 May; 69(5):2968-76. PubMed ID: 7707523
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers.
Rowe M; Peng-Pilon M; Huen DS; Hardy R; Croom-Carter D; Lundgren E; Rickinson AB
J Virol; 1994 Sep; 68(9):5602-12. PubMed ID: 7520093
[TBL] [Abstract][Full Text] [Related]
14. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1.
Peng M; Lundgren E
Leukemia; 1993 Jan; 7(1):104-12. PubMed ID: 8093369
[TBL] [Abstract][Full Text] [Related]
15. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
Peng M; Lundgren E
Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules.
Kasprzak A; Spachacz R; Wachowiak J; Stefanska K; Zabel M
Folia Histochem Cytobiol; 2007; 45(3):169-79. PubMed ID: 17951165
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus involvement in T-cell malignancy: significance in adult T-cell leukemia.
Ohtsubo H; Arima N; Tei C
Leuk Lymphoma; 1999 May; 33(5-6):451-8. PubMed ID: 10342573
[TBL] [Abstract][Full Text] [Related]
19. Classification and biological nature of established human hematopoietic cell lines.
Nilsson K; Pontén J
Int J Cancer; 1975 Feb; 15(2):321-41. PubMed ID: 165156
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
